130 related articles for article (PubMed ID: 8394843)
1. The modulation by nedocromil sodium of proteases released from rat peritoneal mast cells capable of degrading vasoactive intestinal peptide and calcitonin gene-related peptide.
Wilsoncroft P; Gaffen Z; Reynia S; Brain SD
Immunopharmacology; 1993; 25(3):197-204. PubMed ID: 8394843
[TBL] [Abstract][Full Text] [Related]
2. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
Caughey GH; Leidig F; Viro NF; Nadel JA
J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
[TBL] [Abstract][Full Text] [Related]
3. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
Franconi GM; Graf PD; Lazarus SC; Nadel JA; Caughey GH
J Pharmacol Exp Ther; 1989 Mar; 248(3):947-51. PubMed ID: 2495355
[TBL] [Abstract][Full Text] [Related]
4. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin.
Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976
[TBL] [Abstract][Full Text] [Related]
5. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
6. Degradation of airway neuropeptides by human lung tryptase.
Tam EK; Caughey GH
Am J Respir Cell Mol Biol; 1990 Jul; 3(1):27-32. PubMed ID: 1694672
[TBL] [Abstract][Full Text] [Related]
7. Nedocromil sodium modulates the function of long-term rat peritoneal mast cell cultures.
Shalit M; Riesel-Yaron N; Levi-Schaffer F
Pharmacol Res; 1992; 26(3):293-303. PubMed ID: 1279649
[TBL] [Abstract][Full Text] [Related]
8. Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg.
Kajita T; Hugli TE
Am J Pathol; 1991 Jun; 138(6):1359-69. PubMed ID: 2053593
[TBL] [Abstract][Full Text] [Related]
9. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.
Kido H; Fukusen N; Katunuma N
Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754
[TBL] [Abstract][Full Text] [Related]
10. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
[TBL] [Abstract][Full Text] [Related]
11. Effect of nedocromil sodium on the compound exocytosis of mast cells.
Enerbäck L; Bergström S
Drugs; 1989; 37 Suppl 1():44-50; discussion 69-77. PubMed ID: 2474429
[TBL] [Abstract][Full Text] [Related]
12. Characterization of primate bronchoalveolar mast cells. II. Inhibition of histamine, LTC4, and PGD2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells.
Wells E; Jackson CG; Harper ST; Mann J; Eady RP
J Immunol; 1986 Dec; 137(12):3941-5. PubMed ID: 2431049
[TBL] [Abstract][Full Text] [Related]
13. Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide.
Ottosson A; Edvinsson L
Cephalalgia; 1997 May; 17(3):166-74. PubMed ID: 9170339
[TBL] [Abstract][Full Text] [Related]
14. Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from mast cells from various locations.
Pearce FL; Al-Laith M; Bosman L; Brostoff J; Cunniffe TM; Flint KC; Hudspith BN; Jaffar ZH; Johnson NM; Kassessinoff TA
Drugs; 1989; 37 Suppl 1():37-43; discussion 69-77. PubMed ID: 2474428
[TBL] [Abstract][Full Text] [Related]
15. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.
Lowman MA; Benyon RC; Church MK
Br J Pharmacol; 1988 Sep; 95(1):121-30. PubMed ID: 2464382
[TBL] [Abstract][Full Text] [Related]
16. Peptide contents of neuropeptide Y, vasoactive intestinal polypeptide, and beta-calcitonin gene-related peptide and their messenger ribonucleic acids after dexamethasone treatment in the isolated rat islets of Langerhans.
Jamal H; Jones PM; Byrne J; Suda K; Ghatei MA; Kanse SM; Bloom SR
Endocrinology; 1991 Dec; 129(6):3372-80. PubMed ID: 1954911
[TBL] [Abstract][Full Text] [Related]
17. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic assay for tryptase based on the hydrolysis of dansyl-vasoactive intestinal peptide.
Delaria K; Muller D
Anal Biochem; 1996 Apr; 236(1):74-81. PubMed ID: 8619498
[TBL] [Abstract][Full Text] [Related]
19. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
He S; Gaça MD; Walls AF
Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
[TBL] [Abstract][Full Text] [Related]
20. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine.
Okayama Y; Benyon RC; Rees PH; Lowman MA; Hillier K; Church MK
Clin Exp Allergy; 1992 Mar; 22(3):401-9. PubMed ID: 1375128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
